Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Oncotarget|July 11, 2019
Detecting predictive androgen receptor modifications in circulating prostate cancer cellsJulie Steinestel, Manuel Luedeke, Annette Arndt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 29, 2009
Predisposition for TMPRSS2-ERG fusion in prostate cancer by variants in DNA repair genesManuel Luedeke, Carmen M Linnert, Matthias D Hofer, et al.
International Journal of Cancer|October 19, 2017
A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacityHarald Surowy, Dominic Varga, Barbara Burwinkel, et al.
International Journal of Obesity (2005)|March 24, 2018
Early childhood BMI trajectories in monogenic obesity due to leptin, leptin receptor, and melanocortin 4 receptor deficiencyKatja Kohlsdorf, Adriana Nunziata, Jan-Bernd Funcke, et al.
Clinical Epigenetics|December 23, 2015
Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumorsMilan S Geybels, Joshi J Alumkal, Manuel Luedeke, et al.
Frontiers in Neurology|December 21, 2023
Prospective evaluation of NGS-based sequencing in epilepsy patients: results of seven NASGE-associated diagnostic laboratoriesMaximilian G W Witzel, Christian Gebhard, Sören Wenzel, et al.
Human Molecular Genetics|November 1, 2016
Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion statusManuel Luedeke, Antje E Rinckleb, Liesel M FitzGerald, et al.
Human Genetics|June 6, 2016
Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21Craig C Teerlink, Daniel Leongamornlert, Tokhir Dadaev, et al.
Human Genetics|October 16, 2012
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)Jianfeng Xu, Ethan M Lange, Lingyi Lu, et al.
European Journal of Human Genetics : EJHG|June 10, 2020
The effect of sample size on polygenic hazard models for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Pageof 4